Tenax Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $6.2M | $23.3M | $10.0M |
| FY2017 | $1.0M | $9.9M | $1.6M |
| FY2018 | $1.6M | $13.3M | $12.4M |
| FY2019 | $2.6M | $6.4M | $4.9M |
| FY2020 | $2.2M | $6.9M | $6.3M |
| FY2021 | $1.7M | $6.0M | $5.6M |
| FY2022 | $1.9M | $3.4M | $2.1M |
| FY2023 | $3.6M | $11.7M | $9.8M |
| FY2024 | $4.7M | $96.7M | $94.9M |
| FY2025 | $7.2M | $104.2M | $97.6M |